FIELD: chemistry.
SUBSTANCE: invention relates to compound of formula I
, which represents agent of in vivo visualisation of peripheral benzodiazepine receptor (PBR), where Q represents hydrogen or fluorine; X represents hydrogen or C1-4alkoxy; Y represents S; and R represents C1-6fluoroalkyl; and where, at least, one atom of said agent of in vivo visualisation of formula I represents radioisotope, suitable for in vivo visualisation and representing either gamma-emitting radioactive halogen or positron-emitting radioactive non-metal; and where if said radioisotope is a carbon radioisotope, it is carbonyl carbon.
EFFECT: obtaining novel derivatives.
15 cl, 2 dwg, 1 tbl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TRICYCLIC INDOLE DERIVATIVES AS PBR LIGANDS | 2010 |
|
RU2525196C2 |
| DERIVATIVES OF TRICYCLIC INDOLE AS PBR LIGANDS | 2011 |
|
RU2551423C2 |
| PSMA-BINDING AGENTS AND USING THEM | 2009 |
|
RU2494096C2 |
| TETRACYCLIC COMPOUNDS | 2010 |
|
RU2725140C2 |
| TETRACYCLIC COMPOUNDS | 2010 |
|
RU2585622C2 |
| NOVEL 2-HETEROARYL-SUBSTITUTED BENZOTHIOPHENES AND BENZOFURANS 709 | 2008 |
|
RU2472789C2 |
| 2,6-SUBSTUTED-4-MONOSUBSTITUTED AMINO-PYRIMIDINES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS | 2005 |
|
RU2417990C2 |
| ALKYL SULPHONAMIDE QUINOLINES WITH AFFINITY TO NK-3 RECEPTORS | 2006 |
|
RU2421447C2 |
| COMPOSITIONS AND METHODS FOR JAK PATH INHIBITION | 2011 |
|
RU2672100C2 |
| BETA-LACTAMASE INHIBITORS | 2013 |
|
RU2654692C2 |
Authors
Dates
2014-04-10—Published
2009-10-02—Filed